(CEMB) iShares J.P. Morgan EM - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US4642862514

Corporate Bonds, Emerging Markets, Fixed Income Securities

Description: CEMB iShares J.P. Morgan EM

The iShares J.P. Morgan EM Corporate Bond ETF (CEMB) is an exchange-traded fund that tracks the performance of corporate bonds issued by companies in emerging markets, excluding Japan. The fund invests at least 80% of its assets in the underlying indexs component securities and at least 90% in fixed income securities that are representative of the underlying index.

To evaluate the funds performance, key metrics to consider include its yield, duration, and credit quality. The funds yield is likely to be higher than that of developed market corporate bonds, given the higher yields typically associated with emerging market debt. The funds duration will indicate its sensitivity to changes in interest rates, with longer durations indicating greater sensitivity. Credit quality is also crucial, as emerging market corporate bonds can be subject to higher credit risk.

Some key performance indicators (KPIs) for CEMB include its expense ratio, tracking error, and Sharpe ratio. The expense ratio will indicate the funds costs relative to its assets, while the tracking error will measure the funds ability to replicate the performance of its underlying index. The Sharpe ratio will provide a risk-adjusted measure of the funds returns, allowing investors to evaluate its performance relative to its risk.

Investors should also consider the funds diversification benefits, as emerging market corporate bonds can provide a distinct return stream relative to other asset classes. Additionally, the funds liquidity and trading costs should be evaluated, as these can impact investors ability to enter or exit positions. Overall, CEMB can be a useful tool for investors seeking exposure to emerging market corporate bonds, but its performance and characteristics should be carefully evaluated.

CEMB ETF Overview

Market Cap in USD 393m
Category Emerging Markets Bond
TER 0.50%
IPO / Inception 2012-04-17

CEMB ETF Ratings

Growth Rating 34.7%
Fundamental -
Dividend Rating 66.2%
Return 12m vs S&P 500 -8.07%
Analyst Rating -

CEMB Dividends

Dividend Yield 12m 5.23%
Yield on Cost 5y 5.61%
Annual Growth 5y 2.06%
Payout Consistency 96.5%
Payout Ratio %

CEMB Growth Ratios

Growth Correlation 3m 98.2%
Growth Correlation 12m 77.2%
Growth Correlation 5y 21%
CAGR 5y 1.85%
CAGR/Max DD 5y 0.09
Sharpe Ratio 12m 0.82
Alpha 0.91
Beta 0.104
Volatility 2.82%
Current Volume 14.8k
Average Volume 20d 24.2k
Stop Loss 44.3 (-3.2%)
Signal 0.00

What is the price of CEMB shares?

As of August 21, 2025, the stock is trading at USD 45.75 with a total of 14,777 shares traded.
Over the past week, the price has changed by -0.15%, over one month by +1.28%, over three months by +3.85% and over the past year by +6.30%.

Is iShares J.P. Morgan EM a good stock to buy?

Neither. Based on ValueRay´s Analyses, iShares J.P. Morgan EM is currently (August 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 34.65 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CEMB is around 44.54 USD . This means that CEMB is currently overvalued and has a potential downside of -2.64%.

Is CEMB a buy, sell or hold?

iShares J.P. Morgan EM has no consensus analysts rating.

What are the forecasts/targets for the CEMB price?

Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 48.7 6.5%

Last update: 2025-08-13 04:34

CEMB Fundamental Data Overview

Market Cap USD = 393.1m (393.1m USD * 1.0 USD.USD)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.77
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 393.1m USD (393.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 393.1m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 393.1m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(393.1m)/V(0.0) * Re(6.40%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 6.40% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)

Additional Sources for CEMB ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle